Drugs for Rare Diseases – Yukon Agreement Backgrounder

Today, the Government of Canada and the territory of Yukon signed the National Strategy for Drugs for Rare Disease (DRD) agreement to invest over $8.5 million over three years to improve access to new drugs for rare diseases for residents and to support enhanced access to existing drugs, early diagnosis, and screening for rare diseases.

Leave a Comment

Your email address will not be published. Required fields are marked *

Scroll to Top